{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:35:08Z","timestamp":1790922908423,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.radonc.2023.110054","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:14:39Z","timestamp":1702606479000},"page":"110054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Which tumour factors preclude organ preservation in patients with rectal cancer?"],"prefix":"10.1016","volume":"191","author":[{"given":"Anna","family":"Ho\u0142dakowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Kurkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Pietrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4366-6104","authenticated-orcid":false,"given":"Wojciech","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-4331","authenticated-orcid":false,"given":"Tomasz","family":"Olesi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cencelewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1005-0122","authenticated-orcid":false,"given":"Martin","family":"Rydzi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3758-5511","authenticated-orcid":false,"given":"Joanna","family":"Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.110054_b0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.radonc.2023.110054_b0010","doi-asserted-by":"crossref","first-page":"e065010","DOI":"10.1136\/bmjopen-2022-065010","article-title":"Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial","volume":"13","author":"Verweij","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2023.110054_b0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/SLA.0000000000005507","volume":"277","author":"Wang","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2023.110054_b0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2021.05.014","article-title":"Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies","volume":"160","author":"Jankowski","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/0284186X.2022.2117571","article-title":"The utility of short-course radiotherapy in a watch-and-wait strategy for rectal cancer - the need to measure the interval to tumour response assessment from the radiation start","volume":"61","author":"Pietrzak","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1080\/0284186X.2017.1327721","article-title":"The feasibility of short-course radiotherapy in a watch-and-wait policy for rectal cancer","volume":"56","author":"Bujko","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0035","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.ejso.2016.08.001","article-title":"Does the addition of oxaliplatin to preoperative chemoradiation benefit cT4 or fixed cT3 rectal cancer treatment? A subgroup analysis from a prospective study","volume":"42","author":"Wi\u015bniowska","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0040","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.rpor.2020.08.002","article-title":"Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study","volume":"25","author":"Kosakowska","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.radonc.2023.110054_b0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.radonc.2018.12.024","article-title":"A systematic review and meta-analysis of pT2 rectal cancer spread and recurrence pattern: Implications for target design in radiation therapy for organ preservation","volume":"133","author":"Socha","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0050","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","article-title":"Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting","volume":"28","author":"Beets-Tan","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2023.110054_b0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1200\/JCO.18.00032","article-title":"Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3\/4 rectal cancer","volume":"37","author":"Ogura","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0060","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejca.2013.12.007","article-title":"Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy","volume":"50","author":"Yu","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.110054_b0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bjs.5917","article-title":"Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer","volume":"95","author":"Smith","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2023.110054_b0070","unstructured":"Gray B. cmprsk: Subdistribution Analysis of Competing Risks. R package version 2.2-11. https:\/\/CRAN.R-project.org\/package=cmprsk, [accessed 30 June 2023."},{"key":"10.1016\/j.radonc.2023.110054_b0075","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/, [accessed 30 June 2023]."},{"key":"10.1016\/j.radonc.2023.110054_b0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2015.04.003","article-title":"Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12\/PRODIGE 2 randomized trial","volume":"115","author":"G\u00e9rard","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0085","first-page":"92","article-title":"Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2\u2013T3 M0: The time\/dose factor influence","volume":"24","author":"Benezery","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2019.01.034","article-title":"Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study","volume":"133","author":"Rijkmans","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0095","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3619","article-title":"Clinical and radiological predictors of organ preservation in patients with rectal cancer treated with total neoadjuvant therapy","volume":"40","author":"Yuval","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0100","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/DCR.0000000000002122","article-title":"Organ preservation in patients with rectal cancer treated with total neoadjuvant therapy","volume":"64","author":"Jimenez-Rodriguez","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2023.110054_b0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2021.10.004","article-title":"Clinical complete response in patients with rectal adenocarcinoma treated with short-course radiation therapy and nonoperative management","volume":"112","author":"Chin","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110054_b0110","article-title":"Clinico-pathological predictors of clinical complete response in rectal cancer","volume":"31","author":"Mbanu","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.radonc.2023.110054_b0115","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1080\/0284186X.2022.2122866","article-title":"The importance of measuring baseline tumour volume (or alternatively tumour length along with its rectal circumferential extent) in the watch-and-wait strategy in rectal cancer: a review 2022","volume":"61","author":"Ho\u0142dakowska","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S2468-1253(18)30301-7","article-title":"Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis","volume":"3","author":"Chadi","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.radonc.2023.110054_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(97)00215-6","article-title":"Tumor volume: a basic and specific response predictor in radiotherapy","volume":"47","author":"Dubben","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/DCR.0000000000001337","article-title":"Organ preservation among patients with clinically node-positive rectal cancer: is it really more dangerous?","volume":"62","author":"Habr-Gama","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2023.110054_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejso.2019.07.012","article-title":"The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases","volume":"46","author":"Asoglu","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/CMAR.S286796","article-title":"Effect of simultaneous integrated boost intensity modulated radiation therapy (SIB-IMRT) and non-operative strategy on outcomes of distal rectal cancer patients with clinically positive lateral pelvic lymph node","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.radonc.2023.110054_b0145","doi-asserted-by":"crossref","first-page":"zrac039","DOI":"10.1093\/bjsopen\/zrac039","article-title":"Mucinous rectal cancers: clinical features and prognosis in a population-based cohort","volume":"6","author":"Enblad","year":"2022","journal-title":"BJS Open"},{"key":"10.1016\/j.radonc.2023.110054_b0150","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fonc.2015.00286","article-title":"Predictors of complete response and disease recurrence following chemoradiation for rectal cancer","volume":"5","author":"Bitterman","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.110054_b0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/DCR.0000000000002654","article-title":"Circumferential resection margin as predictor of nonclinical complete response in nonoperative management of rectal cancer","volume":"66","author":"Chin","year":"2023","journal-title":"Dis Colon Rectum"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:15Z","timestamp":1759123575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023093611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":31,"alternative-id":["S0167814023093611"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110054","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which tumour factors preclude organ preservation in patients with rectal cancer?","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110054"}}